Laman UtamaTWST • NASDAQ
add
Twist Bioscience Corp
$49.11
Selepas Waktu Dagangan:(2.87%)-1.41
$47.70
Tutup: 13 Feb, 6:20:32 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$47.66
Julat hari
$47.62 - $50.17
Julat tahun
$23.30 - $51.00
Permodalan pasaran
3.01B USD
Bilangan Purata
1.47J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 103.70J | 16.89% |
Perbelanjaan pengendalian | 86.87J | 12.12% |
Pendapatan bersih | -30.51J | 3.44% |
Margin untung bersih | -29.42 | 17.38% |
Pendapatan bagi setiap syer | -0.50 | 5.66% |
EBITDA | -27.01J | 5.45% |
Kadar cukai berkesan | -0.84% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 197.95J | -26.91% |
Jumlah aset | 638.08J | 4.85% |
Jumlah liabiliti | 181.99J | 19.23% |
Jumlah ekuiti | 456.10J | — |
Syer tertunggak | 61.31J | — |
Harga kepada buku | 6.41 | — |
Pulangan pada aset | -12.85% | — |
Pulangan pada modal | -14.52% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -30.51J | 3.44% |
Tunai daripada operasi | -24.81J | -15.80% |
Tunai daripada pelaburan | -9.93J | -546.68% |
Tunai daripada pembiayaan | 298.00K | -98.34% |
Perubahan bersih dalam tunai | -34.44J | -578.89% |
Aliran tunai bebas | -25.86J | -130.04% |
Perihal
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Diasaskan
2013
Tapak web
Pekerja
979
